Navidea Biopharmaceuticals Overview
- Year Founded
-
1983
- Status
-
Public
- Employees
-
19
- Stock Symbol
-
NAVBQ
Navidea Biopharmaceuticals General Information
Description
Navidea Biopharmaceuticals Inc is a biotechnology company specializied in precision medicine. Its products, precision immunodiagnostic agents and immunotherapeutic products are designed to assist in the identification of undetected diseases and to improve targeted treatment. The company's platform, known as Manocept technology, aims to develop next-generation targeted diagnostics and therapies for cancer, autoimmune conditions, and other inflammatory diseases. One of the company's products is Lymphoseek, a radioactive diagnostic agent indicated to locate lymph nodes.
Contact Information
Website
www.navidea.comCorporate Office
- 4100 Horizons Drive
- Suite 205
- Columbus, OH 43220
- United States
Corporate Office
- 4100 Horizons Drive
- Suite 205
- Columbus, OH 43220
- United States
Navidea Biopharmaceuticals Stock Performance
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| 21.2K |
Navidea Biopharmaceuticals Financials Summary
As of 30-Sep-2023, Navidea Biopharmaceuticals has a trailing 12-month revenue of $610.00.
|
In Thousands, USD |
TTM 30-Sep-2023 | FY 2022 31-Dec-2022 | FY 2021 31-Dec-2021 | FY 2020 31-Dec-2020 |
|---|---|---|---|---|
| EV | 4,465 | 4,308 | 24,124 | 55,418 |
| Revenue | 1 | 15 | 46 | 119 |
| EBITDA | (8,502) | (13,983) | (11,632) | (10,663) |
| Net Income | (1,182) | (15,177) | (11,731) | (10,722) |
| Total Assets | 5,699 | 4,372 | 6,645 | 7,758 |
| Total Debt | 1,260 | 2,436 | 749 | 1,336 |
Navidea Biopharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Navidea Biopharmaceuticals Comparisons
Industry
Financing
Details
Navidea Biopharmaceuticals Competitors (12)
One of Navidea Biopharmaceuticals’s 12 competitors is Inovio Pharmaceuticals, a Corporation company based in Plymouth Meeting, PA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Inovio Pharmaceuticals | Corporation | Plymouth Meeting, PA | ||||
| Marker Therapeutics | Formerly VC-backed | Houston, TX | ||||
| Fate Therapeutics | Formerly VC-backed | San Diego, CA | ||||
| Curis | Formerly VC-backed | Lexington, MA | ||||
| Checkpoint Therapeutics | Corporate Backed or Acquired | Waltham, MA |
Navidea Biopharmaceuticals Patents
Navidea Biopharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| JP-2025535006-A | Amide linkage of the sugar moiety to an amine-terminated leash attached to a carbohydrate polymer | Pending | 03-Oct-2022 | ||
| EP-4598583-A2 | Amide linkages of sugar moieties to amine terminated leashes attached to carbohydrate polymers | Pending | 03-Oct-2022 | ||
| US-12404349-B2 | Amide linkages of sugar moieties to amine terminated leashes attached to carbohydrate polymers | Active | 03-Oct-2022 | ||
| US-20240132630-A1 | Amide linkages of sugar moieties to amine terminated leashes attached to carbohydrate polymers | Active | 03-Oct-2022 | ||
| US-20250382392-A1 | Amide linkages of sugar moieties to amine terminated leashes attached to carbohydrate polymers | Inactive | 03-Oct-2022 | C08B37/0021 |
Navidea Biopharmaceuticals Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Navidea Biopharmaceuticals ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Biotechnology
Subindustry
Rank
Percentile
Navidea Biopharmaceuticals Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Cardinal Milestone Payment |
Navidea Biopharmaceuticals FAQs
-
When was Navidea Biopharmaceuticals founded?
Navidea Biopharmaceuticals was founded in 1983.
-
Where is Navidea Biopharmaceuticals headquartered?
Navidea Biopharmaceuticals is headquartered in Columbus, OH.
-
What is the size of Navidea Biopharmaceuticals?
Navidea Biopharmaceuticals has 19 total employees.
-
What industry is Navidea Biopharmaceuticals in?
Navidea Biopharmaceuticals’s primary industry is Drug Discovery.
-
Is Navidea Biopharmaceuticals a private or public company?
Navidea Biopharmaceuticals is a Public company.
-
What is Navidea Biopharmaceuticals’s stock symbol?
The ticker symbol for Navidea Biopharmaceuticals is NAVBQ.
-
What is Navidea Biopharmaceuticals’s current revenue?
The trailing twelve month revenue for Navidea Biopharmaceuticals is $610.00.
-
Who are Navidea Biopharmaceuticals’s competitors?
Inovio Pharmaceuticals, Marker Therapeutics, Fate Therapeutics, Curis, and Checkpoint Therapeutics are some of the 12 competitors of Navidea Biopharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
